Explain some of the concerns of treating young people with depression with medications

What will be an ideal response?

The main concerns are possible serious side effects such as suicidal thoughts and self-harm and a lack of information about the long-term effects of these medications on the developing brain. Related to these concerns and warnings by the FDA, the use of SSRIs with young people has decreased by about 20% in more recent years (Gibbons et al., 2007; Libby et al., 2007). In 2004, the FDA asked all manufacturers of antidepressant medications to include in their labeling a boxed warning (black box) and Patient Education Guide to alert consumers about the increased risk of suicidal thinking and behavior in youngsters treated with these medications.